fda semaglutide compounding enforcement october 2025 Out of Shortage, Into Controversy: The Fight Over GLP-1 fda compounding semaglutide enforcement october
Description
Peptidomimetics - Tailored Enzyme-Inhibitors
Yes, semaglutide from Hers is legitimate, but with an important caveat
The FDA is worried about a few things
That said, switching to the Wegovy pill is not automatically simpler than staying on the injection
Compounded semaglutide (in 2026)
In 2026, AstraZenecas partnership with Chinas CSPC reflects growing interest in accessing Chinese innovation and manufacturing capabilities
